Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility

Diabetes. 1992 Mar;41(3):378-84. doi: 10.2337/diab.41.3.378.

Abstract

Insulin-dependent diabetes mellitus (IDDM) in whites is strongly associated with particular HLA-DQ alpha beta heterodimers composed of a DQ alpha chain with an arginine at residue 52 (Arg52+) combined to a DQ beta chain lacking an aspartic acid at residue 57 (Asp57-). With the aim of confirming this association, clarifying which heterodimers account for the highest risk of IDDM and explaining the excess risk of DR3-DQw2/DR4-DQw8, 115 unrelated white IDDM patients and 108 unrelated healthy nondiabetic control subjects were studied. With polymerase chain reaction and sequence-specific oligonucleotide probes, both patients and control subjects were typed for their HLA-DQA1 and DQB1 alleles and their DQA1-DQB1 haplotype and genotype frequencies were compared. Four major findings emerged from our analysis. 1) Arg52+ DQ alpha/Asp57- DQ beta heterodimers, formed in cis and/or in trans, are strongly associated with susceptibility to IDDM; 97% of patients and 46% of control subjects had at least one such susceptibility heterodimer (relative risk [RR] 32, confidence interval [Cl] 14.25-71.86, P less than 10(-7). 2) The degree of disease susceptibility depends on the number of such DQ heterodimers that a subject can express according to his or her DQA1-DQB1 genotype. The highest RR was observed in patients with four susceptibility DQ heterodimers (RR 41, Cl 17.05-95.9). 3) Only part of the susceptibility DQ heterodimers were significantly increased in patients, conferring IDDM susceptibility of different strength. The strongest association was with the DQA1*0501-DQB1*0302 combination formed in trans position (RR 35.2, CI 12.88-96.78, P less than 10(-7).(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Amino Acid Sequence
  • Base Sequence
  • Cell Line
  • DNA / genetics
  • DNA / isolation & purification
  • Diabetes Mellitus, Type 1 / genetics
  • Diabetes Mellitus, Type 1 / immunology*
  • Disease Susceptibility
  • Gene Frequency
  • Genotype
  • HLA-D Antigens / genetics
  • HLA-DQ Antigens / genetics*
  • Haplotypes
  • Histocompatibility Testing
  • Humans
  • Macromolecular Substances
  • Molecular Sequence Data
  • Oligodeoxyribonucleotides
  • Oligonucleotide Probes
  • Polymerase Chain Reaction / methods
  • Reference Values
  • Risk Factors

Substances

  • HLA-D Antigens
  • HLA-DQ Antigens
  • Macromolecular Substances
  • Oligodeoxyribonucleotides
  • Oligonucleotide Probes
  • DNA